Limits...
Patterns of complementary and alternative medicine use in children with common neurological conditions.

Treat L, Liesinger J, Ziegenfuss JY, Humeniuk K, Prasad K, Tilburt JC - Glob Adv Health Med (2014)

Bottom Line: The nature of CAM use in this population, as well as its risks and benefits in neurological disease, deserve further investigation.Abstract available from the publisher.

View Article: PubMed Central - PubMed

Affiliation: Mayo Medical School, Mayo Clinic, Rochester, Minnesota (Dr Treat), United States.

ABSTRACT

Background: Recent literature suggests that one in nine children in the United States uses some type of complementary and alternative medicine (CAM). Children with challenging neurological conditions such as headache, migraine, and seizures may seek CAM in their attempts at self-care. Our objective was to describe CAM use in children with these conditions.

Methods: We compared use of CAM among children aged 3 to 17 years with and without common neurological conditions (headaches, migraines, seizures) where CAM might plausibly play a role in their self-management using the 2007 National Health Interview Survey (NHIS) data.

Results: Children with common neurological conditions reported significantly more CAM use compared to the children without these conditions (24.0% vs 12.6%, P<.0001). Compared to other pediatric CAM users, children with neurological conditions report similarly high use of biological therapies and significantly higher use of mind-body techniques (38.6% vs 20.5%, P<.007). Of the mind-body techniques, deep breathing (32.5%), meditation (15.1%), and progressive relaxation (10.1%) were used most frequently.

Conclusions: About one in four children with common neurological conditions use CAM. The nature of CAM use in this population, as well as its risks and benefits in neurological disease, deserve further investigation.

No MeSH data available.


Related in: MedlinePlus

Distribution of the most commonly-used complementary and alternative medicine (CAM) modalities reported by children aged 3 to 17 years with and without neurological conditions (*P < .05).
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3921609&req=5

Figure 1: Distribution of the most commonly-used complementary and alternative medicine (CAM) modalities reported by children aged 3 to 17 years with and without neurological conditions (*P < .05).

Mentions: Comparisons of CAM modalities used by children with and without neurological conditions are presented in Table 3. Use of biologically-based therapies was most prevalent among both groups, and the rate was only slightly higher in children with neurological conditions (43.9% vs 37.8%). The use of mind-body therapies by children with neurological conditions was significantly increased as compared to children without neurological conditions (38.6% vs 20.5%, P < .007; Figure). Therapies used more frequently by children with neurological conditions compared to those without included deep breathing (32.5% vs 17.3%), meditation (15.1% vs 9.1%), and progressive relaxation (10.1% vs 3.1%).


Patterns of complementary and alternative medicine use in children with common neurological conditions.

Treat L, Liesinger J, Ziegenfuss JY, Humeniuk K, Prasad K, Tilburt JC - Glob Adv Health Med (2014)

Distribution of the most commonly-used complementary and alternative medicine (CAM) modalities reported by children aged 3 to 17 years with and without neurological conditions (*P < .05).
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3921609&req=5

Figure 1: Distribution of the most commonly-used complementary and alternative medicine (CAM) modalities reported by children aged 3 to 17 years with and without neurological conditions (*P < .05).
Mentions: Comparisons of CAM modalities used by children with and without neurological conditions are presented in Table 3. Use of biologically-based therapies was most prevalent among both groups, and the rate was only slightly higher in children with neurological conditions (43.9% vs 37.8%). The use of mind-body therapies by children with neurological conditions was significantly increased as compared to children without neurological conditions (38.6% vs 20.5%, P < .007; Figure). Therapies used more frequently by children with neurological conditions compared to those without included deep breathing (32.5% vs 17.3%), meditation (15.1% vs 9.1%), and progressive relaxation (10.1% vs 3.1%).

Bottom Line: The nature of CAM use in this population, as well as its risks and benefits in neurological disease, deserve further investigation.Abstract available from the publisher.

View Article: PubMed Central - PubMed

Affiliation: Mayo Medical School, Mayo Clinic, Rochester, Minnesota (Dr Treat), United States.

ABSTRACT

Background: Recent literature suggests that one in nine children in the United States uses some type of complementary and alternative medicine (CAM). Children with challenging neurological conditions such as headache, migraine, and seizures may seek CAM in their attempts at self-care. Our objective was to describe CAM use in children with these conditions.

Methods: We compared use of CAM among children aged 3 to 17 years with and without common neurological conditions (headaches, migraines, seizures) where CAM might plausibly play a role in their self-management using the 2007 National Health Interview Survey (NHIS) data.

Results: Children with common neurological conditions reported significantly more CAM use compared to the children without these conditions (24.0% vs 12.6%, P<.0001). Compared to other pediatric CAM users, children with neurological conditions report similarly high use of biological therapies and significantly higher use of mind-body techniques (38.6% vs 20.5%, P<.007). Of the mind-body techniques, deep breathing (32.5%), meditation (15.1%), and progressive relaxation (10.1%) were used most frequently.

Conclusions: About one in four children with common neurological conditions use CAM. The nature of CAM use in this population, as well as its risks and benefits in neurological disease, deserve further investigation.

No MeSH data available.


Related in: MedlinePlus